Advertisement
Advertisement

IVA

IVA logo

Inventiva S.A. - ADR

3.46
USD
Sponsored
-0.25
-6.74%
Jun 24, 16:00 UTC -4
Closed
exchange

Pre-Market

3.61

+0.15
+4.34%

IVA Earnings Reports

Positive Surprise Ratio

No Data Available for IVA

0%

Next Report

Date of Next Report
Jul 29, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$0.28
Implied change from Q1 26 (Revenue/ EPS)
--
/
--
Implied change from Q2 25 (Revenue/ EPS)
--
/
--

Inventiva S.A. - ADR earnings per share and revenue

On May 25, 2026, IVA reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference. The market reacted with a +1.78% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -0.28 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
logo
Grace Therapeutics, Inc. Common Stock
Report Date
Jun 18, 2026 For Q4 26
Estimate
-$0.23
Actual
-$0.06
Surprise
+74.42%
logo
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
For Q1 2026, Inventiva S.A. - ADR reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved up 1.78%, changed from $5.07 before the earnings release to $5.16 the day after.
The next earning report is scheduled for Jul 29, 2026.
Based on -- analysts, Inventiva S.A. - ADR is expected to report EPS of -$0.28 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement